Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan.

Blood Neoplasia · 2026 · PMC13234603 · PMID 42255256

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

a nonsignificant trendP = .098so close (0.05 < p ≤ 0.1)

A nonsignificant trend toward correlation between VEN Cmax and AUC0-12 and the duration of grade 3 thrombocytopenia was seen ( r = 0.371, P = .098 for Cmax and r = 0.358, P = .138 for AUC0-12; Figure 4 ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.